Coronavirus envelope protein is a drug target for new platform for the identification and optimization of peptides against SARS-CoV-2
Published 2024-03-14 · Original archive entry · Explore research explainers
Coronavirus envelope protein is a drug target for new platform for the identification and optimization of peptides against SARS-CoV-2
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3002522
Article Title: Developing inhibitory peptides against SARS-CoV-2 envelope protein
Author Countries: United States
Funding: This work was supported by Columbia University Dean’s Office Fund and Columbia University Translational Therapeutics (TRx) Pilot Award (to M.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
END
Attachments
